Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy

S Zhang, J Wang, Z Kong, X Sun, Z He, B Sun, C Luo… - Biomaterials, 2022 - Elsevier
Immunotherapy has emerged as a promising cancer treatment modality. Despite the rapid
progress in cancer immunotherapy, the therapeutic efficiency and clinical translation of …

Necroptosis

A Linkermann, DR Green - New England Journal of Medicine, 2014 - Mass Medical Soc
Necroptosis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

Consensus guidelines for the detection of immunogenic cell death

O Kepp, L Senovilla, I Vitale, E Vacchelli… - …, 2014 - Taylor & Francis
Apoptotic cells have long been considered as intrinsically tolerogenic or unable to elicit
immune responses specific for dead cell-associated antigens. However, multiple stimuli can …

Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy

M Jiang, J Zeng, L Zhao, M Zhang, J Ma, X Guan… - Nanoscale, 2021 - pubs.rsc.org
Chemotherapy has been a conventional paradigm for cancer treatment, and multifarious
chemotherapeutic drugs have been widely employed for decades with significant …

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

J Pol, E Vacchelli, F Aranda, F Castoldi… - …, 2015 - Taylor & Francis
The term “immunogenic cell death”(ICD) is now employed to indicate a functionally peculiar
form of apoptosis that is sufficient for immunocompetent hosts to mount an adaptive immune …

Origin and consequences of necroinflammation

M Sarhan, WG Land, W Tonnus… - Physiological …, 2018 - journals.physiology.org
When cells undergo necrotic cell death in either physiological or pathophysiological settings
in vivo, they release highly immunogenic intracellular molecules and organelles into the …

Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy

S Qu, T Worlikar, AE Felsted, A Ganguly… - Journal for …, 2020 - pmc.ncbi.nlm.nih.gov
Background Develo** the ability to use tumor-directed therapies to trigger potentially
therapeutic immune responses against cancer antigens remains a high priority for cancer …

Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists

T Yamazaki, D Hannani, V Poirier-Colame… - Cell Death & …, 2014 - nature.com
Immunogenic cell death induced by anticancer chemotherapy is characterized by a series of
molecular hallmarks that include the exodus of high-mobility group box 1 protein (HMGB1) …

Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation

AL Pepple, JL Guy, R McGinnis, AE Felsted… - Frontiers in …, 2023 - frontiersin.org
Introduction Histotripsy is a novel focused ultrasound tumor ablation modality with potent
immunostimulatory effects. Methods To measure the spatiotemporal kinetics of local …

[HTML][HTML] Transplantation and damage-associated molecular patterns (DAMPs)

WG Land, P Agostinis, S Gasser, AD Garg… - American Journal of …, 2016 - Elsevier
Upon solid organ transplantation and during cancer immunotherapy, cellular stress
responses result in the release of damage-associated molecular patterns (DAMPs). The …